在甲状腺癌患者中确定131I的有效半衰期,使用远程剂量速率计

Laura Kääriä1, Maria Lapela2, Marko Seppänen3

  • 1Department of Clinical Physiology, Nuclear Medicine, Turku PET Centre, and Medical Physics, Turku University Hospital and Wellbeing services county of Southwest Finland and University of Turku, Turku, Finland. laura.e.kaaria@utu.fi.

EJNMMI physics
|November 28, 2024
PubMed
概括

有高BMI,低GFR或糖尿病的差异化甲状腺癌患者具有更长的放射性 (RAI) 有效半衰期 (Teff). 遥控剂量率计可靠地确定患者Teff,优化隔离时间.